Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967 · see citing works

METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.

Rodbell, M. (1964) · PubMed · Cited by 1,387 · see citing works

Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*

Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 922 · see citing works

Methods for the determination of adipose cell size in man and animals

Hirsch, J., & Gallian, E. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43151-7 · Cited by 894 · see citing works

Insulin Resistance — Mechanisms, Syndromes, and Implications

Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 800 · see citing works

Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction

Kahn, C. R. (1978) · Metabolism · doi:10.1016/s0026-0495(78)80007-9 · Cited by 793 · see citing works

Insulin resistance in nonobese patients with polycystic ovarian disease

CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704 · see citing works

POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE

Franks, S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00457.x · Cited by 523 · see citing works

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

Wallach, E. E., Barbieri, R. L., Smith, S., & Ryan, K. J. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60060-2 · Cited by 348 · see citing works

Insulin-Resistant Diabetes Due to a Point Mutation That Prevents Insulin Proreceptor Processing

Yoshimasa, Y., Seino, S., Whittaker, J., Kakehi, T., Kosaki, A., Kuzuya, H., Imura, H., Bell, G. I., & Steiner, D. F. (1988) · Science · doi:10.1126/science.3283938 · Cited by 254 · see citing works

Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.

Freidenberg, G. R., Henry, R. R., Klein, H. H., Reichart, D. R., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112789 · Cited by 234 · see citing works

Suppression of Hyperandrogenism Does not Improve Peripheral or Hepatic Insulin Resistance in the Polycystic Ovary Syndrome*

Dunaif, A. E., Green, G., Futterweit, W., & Dobrjansky, A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-699 · Cited by 198 · see citing works

Insulin resistance in polycystic ovary syndrome

Shoupe, D., Kumar, D. D., & Løbo, R. A. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90023-6 · Cited by 194 · see citing works

Acanthosis nigricans in Obese Women with Hyperandrogenism: Characterization of an Insulin-Resistant State Distinct from the Type A and B Syndromes

Flier, J. S., Eastman, R. C., Minaker, K. L., Matteson, D., & Rowe, J. W. (1985) · Diabetes · doi:10.2337/diab.34.2.101 · Cited by 179 · see citing works

Detection of an Alteration in the Insulin-Receptor Gene in a Patient with Insulin Resistance, Acanthosis Nigricans, and the Polycystic Ovary Syndrome (Type A Insulin Resistance)

Moller, D. E., & Flier, J. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192306 · Cited by 154 · see citing works

Role of Glucose Transport in the Postreceptor Defect of Non-insulin-dependent Diabetes Mellitus

Ciaraldi, T. P., Kolterman, O., Scarlett, J. A., Kao, M., & Olefsky, J. M. (1982) · Diabetes · doi:10.2337/diacare.31.11.1016 · Cited by 105 · see citing works

Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels

Pasquali, R., Casimirri, F., Venturoli, S., Paradisi, R., Mattioli, L., Melchionda, N., & Labò, G. (1983) · European Journal of Endocrinology · doi:10.1530/acta.0.1040110 · Cited by 96 · see citing works

Obesity and Polycystic Ovary Syndromea

Franks, S., Kiddy, D. S., Sharp, P. S., Singh, A., Reed, M. J., Seppälä, M. T., Koistinen, R. A., & Hamilton‐Fairley, D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37915.x · Cited by 55 · see citing works

Insulin Resistance and Hyperinsulinemia Induce Hyperandrogenism in a Young Type B Insulin-Resistant Female*

DeClue, T. J., Shah, S. C., MARCHESE, M., & Malone, J. I. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1308 · Cited by 48 · see citing works

Insulin Action Kinetics in Adipocytes from Obese and Noninsulin-Dependent Diabetes Mellitus Subjects: Identification of Multiple Cellular Defects in Glucose Transport*

Ciaraldi, T. P., Molina, J. M., & Olefsky, J. M. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-4-876 · Cited by 28 · see citing works

Sensitivity of Pyruvate Dehydrogenase to Insulin in Activated T Lymphocytes: Lack of Responsiveness to Insulin in Patients With Polycystic Ovarian Disease and Diabetes

Buffington, C. K., Givens, J. R., & Kitabchi, A. E. (1990) · Diabetes · doi:10.2337/diab.39.3.361 · Cited by 13 · see citing works

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,320 · see citing works

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis

Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,761 · see citing works

Polycystic Ovary Syndrome

Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463 · see citing works

Polycystic ovary syndrome

Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · see citing works

The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited

Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · see citing works

Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women¹

Legro, R. S., Kunselman, A. R., Dodson, W. C., & Dunaif, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5393 · Cited by 1,537 · see citing works

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · see citing works

Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome

Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · see citing works

Polycystic ovary syndrome

Lawrence, J., Douglas, P., & Gandy, J. (2016) · doi:10.1002/9781119163411.ch73 · Cited by 1,014 · see citing works

Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931 · see citing works

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865 · see citing works

Obesity and the polycystic ovary syndrome

Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 838 · see citing works

The Insulin-Related Ovarian Regulatory System in Health and Disease

Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 839 · see citing works

Polycystic ovary syndrome

Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 802 · see citing works

Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome

Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743 · see citing works

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589 · see citing works

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · see citing works

Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin

Urbanek, M., Legro, R. S., Driscoll, D. A., Azziz, R., Ehrmann, D. A., Norman, R. J., Strauss, J. F., Spielman, R. S., & Dunaif, A. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8573 · Cited by 483 · see citing works

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

Morales, A. J., Laughlin, G. A., Bützow, T. L., Maheshwari, H., Baumann, G., & Yen, S. S. C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768842 · Cited by 453 · see citing works

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome

Dunaif, A. E., & Finegood, D. T. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772555 · Cited by 453 · see citing works

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Ehrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., & Polonsky, K. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118064 · Cited by 426 · see citing works

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

Ovalle, F., & Azziz, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03111-4 · Cited by 428 · see citing works

Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.

Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371 · see citing works

Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17α Activity and Serum Androgens1

Nestler, J. E., & Jakubowicz, D. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4431 · Cited by 368 · see citing works

Insulin and hyperandrogenism in women with polycystic ovary syndrome

Baptiste, C. G., Battista, M., Trottier, A., & Baillargeon, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.010 · Cited by 368 · see citing works

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337 · see citing works

Sex steroids and insulin resistance

Livingstone, C., & Collison, M. (2002) · Clinical Science · doi:10.1042/cs1020151 · Cited by 307 · see citing works

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Diamanti-Kandarakis, E., & Papavassiliou, A. G. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.006 · Cited by 301 · see citing works

Molecular mechanisms of insulin resistance and associated diseases

Mlinar, B., Marc, J., Janež, A., & Pfeifer, M. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.005 · Cited by 297 · see citing works

Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification

Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300 · see citing works

Current Concepts in the Polycystic Ovary Syndrome

Dunaif, A. E., & Thomas, A. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.401 · Cited by 300 · see citing works

Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications

Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294 · see citing works

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 288 · see citing works

miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance

Chen, Y.-H., Heneidi, S. G., Lee, J.-M., Layman, L. C., Stepp, D. W., Gamboa, G. M., Chen, B.-S., Chazenbalk, G. D., & Azziz, R. (2013) · Diabetes · doi:10.2337/db12-0963 · Cited by 285 · see citing works

Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature

Xu, Y., & Qiao, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9240569 · Cited by 310 · see citing works

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283 · see citing works

Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population

Elting, M. W., Korsen, T. J. M., Bezemer, P. D., & Schoemaker, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.556 · Cited by 253 · see citing works

The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women

Moghetti, P., Tosi, F., Castello, R., Magnani, C. M., Negri, C., Brun, E., Furlani, L., Caputo, M., & Muggeo, M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772557 · Cited by 242 · see citing works

Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

Dunaif, A. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80057-6 · Cited by 235 · see citing works

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

Nestler, J. E., Stovall, D. W., Akhter, N., Iuorno, M. J., & Jakubowicz, D. J. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02963-6 · Cited by 230 · see citing works

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome

Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., & Tapanainen, J. S. (2000) · Human Reproduction · doi:10.1093/humrep/15.6.1266 · Cited by 227 · see citing works

Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes

Gambineri, A., Patton, L., Altieri, P., Pagotto, U., Pizzi, C., Manzoli, L., & Pasquali, R. (2012) · Diabetes · doi:10.2337/db11-1360 · Cited by 226 · see citing works

Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes

ROSENBAUM, D. S., Haber, R. S., & Dunaif, A. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e197 · Cited by 223 · see citing works

Should all women with PCOS be treated for insulin resistance?

Marshall, J. C., & Dunaif, A. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.036 · Cited by 217 · see citing works

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

Iuorno, M. J., Jakubowicz, D. J., Baillargeon, J.-P., Dillon, P., Gunn, R. D., Allan, G., & Nestler, J. E. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.417 · Cited by 188 · see citing works

Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome

Yaralı́, H., Yı́ldı́rı́r, A., Aybar, F., Kabakçı, G., Bükülmez, O., Akgül, E., & Oto, A. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01937-9 · Cited by 188 · see citing works

Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women

Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184 · see citing works

MetforminVersusEthinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study

Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., Martikainen, H. K., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020997 · Cited by 183 · see citing works

INSULIN ACTION IN THE POLYCYSTIC OVARY SYNDROME

Dunaif, A. E. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70073-6 · Cited by 181 · see citing works

Basic Infertility Including Polycystic Ovary Syndrome

Brassard, M., Ainmelk, Y., & Baillargeon, J. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.04.008 · Cited by 181 · see citing works

Androgen biosynthesis from cholesterol to DHEA

Miller, W. L. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00363-5 · Cited by 179 · see citing works

Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome

Goodarzi, M. O., & Azziz, R. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.005 · Cited by 170 · see citing works

A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills

Diamanti‐Kandarakis, E., Baillargeon, J., Iuorno, M. J., Jakubowicz, D. J., & Nestler, J. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021528 · Cited by 170 · see citing works

Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome

Nelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., Legro, R. S., Kimball, S. R., Strauss, J. F., & McAllister, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0178 · Cited by 167 · see citing works

Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism

Apter, D. L., Bützow, T. L., Laughlin, G. A., & YEN, S. S. C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559882 · Cited by 167 · see citing works

Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome

Corbould, A. M., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166 · see citing works

Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ Hyperinsulinemia

Laughlin, G. A., Morales, A. J., & YEN, S. S. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.4028 · Cited by 168 · see citing works

Insulin regulation of human ovarian androgens

Nestler, J. E. (1997) · Human Reproduction · doi:10.1093/humrep/12.suppl_1.53 · Cited by 161 · see citing works

Insulin Augmentation of 17α-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells

Munir, I., Yen, H.-W., Geller, D. H., Torbati, D., Bierden, R. M., Weitsman, S. R., Agarwal, S. K., & Magoffin, D. A. (2003) · Endocrinology · doi:10.1210/en.2003-0329 · Cited by 160 · see citing works

Polycystic ovary syndrome, adipose tissue and metabolic syndrome

Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159 · see citing works

Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome

Wu, X. K., Zhou, S. Y., Liu, J. X., Pöllänen, P., Sallinen, K., Mäkinen, M., & Erkkola, R. U. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01007-0 · Cited by 147 · see citing works

Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?

Corbould, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.872 · Cited by 143 · see citing works

Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome

Holte, J. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80085-1 · Cited by 145 · see citing works

Insulin Resistance in PCOS

Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 137 · see citing works

The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance

Bremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 131 · see citing works

17 -Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight Loss

Jakubowicz, D. J., & Nestler, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3753 · Cited by 137 · see citing works

Skeletal Muscle Insulin Resistance in Endocrine Disease

Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129 · see citing works

Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance

Ciaraldi, T. P., Aroda, V. R., Mudaliar, S. R. D., Chang, R. J., & Henry, R. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1492 · Cited by 128 · see citing works

Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome

Talbot, J. A., Bicknell, E. J., Rajkhowa, M., Krook, A., O’Rahilly, S., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626868 · Cited by 121 · see citing works

A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome

Shele, G., Genkil, J., & Speelman, D. L. (2020) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk5020035 · Cited by 116 · see citing works

Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

Lorenzo, M. D., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 114 · see citing works

Androgen excess is the key element in polycystic ovary syndrome

Azziz, R. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00735-0 · Cited by 111 · see citing works

Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators

Li, M., YOUNGREN, J. F., Dunaif, A. E., Goldfine, I. D., Maddux, B. A., Zhang, B. B., & Evans, J. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020363 · Cited by 111 · see citing works

Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS)

Diamanti‐Kandarakis, E., Argyrakopoulou, G., Economou, F., Kandaraki, E., & Koutsilieris, M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.014 · Cited by 107 · see citing works

Hormone Profiles in Young Adults with Epilepsy Treated with Sodium Valproate or Lamotrigine Monotherapy

Stephen, L. J., Kwan, P., Shapiro, D., Dominiczak, M. H., & Brodie, M. J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.0420081002.x · Cited by 106 · see citing works

Inositol as putative integrative treatment for PCOS

Genazzani, A. D. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.024 · Cited by 106 · see citing works

Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome

Orio, F., Matarese, G., Biase, S. D., Palomba, S., Labella, D., Sanna, V., Savastano, S., Zullo, F., Colao, A., & Lombardi, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021816 · Cited by 106 · see citing works

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

Ünlühızarcı, K., Keleştimur, F., Bayram, F., Şahin, Y., & Tutuş, A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00786.x · Cited by 104 · see citing works

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity

Sathyapalan, T., & Atkin, S. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/758656 · Cited by 104 · see citing works

<i>Polycystic Ovary Syndrome in Adolescence</i>

Blank, S. K., Helm, K. D., McCartney, C. R., & Marshall, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.005 · Cited by 97 · see citing works

Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome

Arner, P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.012 · Cited by 98 · see citing works

Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity 1

Ciaraldi, T. P., Morales, A. J., Hickman, M. G., Odom-Ford, R., Olefsky, J. M., & Yen, S. S. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3961 · Cited by 96 · see citing works

Polycystic Ovary Syndrome in the Pediatric Population

Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 96 · see citing works

Polycystic ovary syndrome: pathogenesis and treatment over the short and long term.

Marx, T. L., & Mehta, A. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.1.31 · Cited by 94 · see citing works

MENSTRUAL DISORDERS IN ADOLESCENTS

Gordon, C. M. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70135-8 · Cited by 92 · see citing works

Thecal Cell Sensitivity to Luteinizing Hormone and Insulin in Polycystic Ovarian Syndrome

Cadagan, D., Khan, R., & Amer, S. (2016) · Reproductive Biology · doi:10.1016/j.repbio.2015.12.006 · Cited by 92 · see citing works

Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome

Mukherjee, S., Shaikh, N. J., Khavale, S., Shinde, G., Meherji, P. K., Shah, N. S., & Maitra, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0932 · Cited by 92 · see citing works

Insulin resistance, insulin‐like growth factor I and breast cancer: A hypothesis

Kazer, R. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620408 · Cited by 93 · see citing works

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis

Sathyapalan, T., David, R., Gooderham, N. J., & Atkin, S. L. (2015) · Scientific Reports · doi:10.1038/srep16890 · Cited by 90 · see citing works

Pathogenesis of polycystic ovary syndrome: what is the role of obesity?

Salehi, M., Bravo-Vera, R., Sheikh, A., Gouller, A., & Poretsky, L. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.005 · Cited by 90 · see citing works

Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction

Józkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 90 · see citing works

Western-style diet, sex steroids and metabolism

Varlamov, O. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.025 · Cited by 89 · see citing works

Morning Circadian Misalignment Is Associated With Insulin Resistance in Girls With Obesity and Polycystic Ovarian Syndrome

Simon, S. L., McWhirter, L., Diniz Behn, C., Bubar, K. M., Kaar, J. L., Pyle, L., Rahat, H., Garcia-Reyes, Y., Carreau, A.-M., Wright, K. P., et al. (2019) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2018-02385 · Cited by 87 · see citing works

Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome

Johansson, J., Feng, Y., Shao, R., Lönn, M., Billig, H., & Stener‐Victorin, E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2010 · Cited by 81 · see citing works

POLYCYSTIC OVARY SYNDROME

Taylor, A. E. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70045-1 · Cited by 81 · see citing works

Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial

George, S. S. (2003) · Human Reproduction · doi:10.1093/humrep/deg105 · Cited by 79 · see citing works

Early steps in androgen biosynthesis: From cholesterol to DHEA

Miller, W. L. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80461-8 · Cited by 77 · see citing works

Insulin-Lowering Drugs In Polycystic Ovary Syndrome

Iuorno, M. J., & Nestler, J. E. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70191-1 · Cited by 79 · see citing works

Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity 1

Ciaraldi, T. P., Morales, A. J., Hickman, M. G., Odom-Ford, R., Olefsky, J. M., & Yen, S. S. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3961 · Cited by 96 · see citing works

Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity.

Ciaraldi, T. (2000) · PubMed · Cited by 25 · see citing works

Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome

Dunaif, A. E., Segal, K. R., Shelley, D., Green, G., Dobrjansky, A., & Licholai, T. (1992) · Diabetes · doi:10.2337/diab.41.10.1257 · Cited by 544 · see citing works

Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity*

Ciaraldi, T. P., Morales, A. J., Hickman, M. G., Odom-Ford, R., Olefsky, J. M., & Yen, S. S. C. (2013)

The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome

Corbould, A. M., & Dunaif, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.021 · Cited by 52 · see citing works